Anpario plc (FRA:KI9A)

Market Cap	131.16M +18.8%
Revenue (ttm)	54.08M +23.5%
Net Income	7.74M +64.2%
EPS	0.43 +55.4%
Shares Out	n/a
PE Ratio	16.95
Forward PE	15.74
Dividend	0.13 (2.16%)
Ex-Dividend Date	Nov 13, 2025

Volume	n/a
Open	6.10
Previous Close	6.20
Day's Range	6.10 - 6.20
52-Week Range	4.12 - 7.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 10, 2026

About Anpario

Anpario plc, together with its subsidiaries, manufactures and distributes natural animal feed additives for animal health, nutrition, and biosecurity. Its health and performance category offers various products that support and maintain animal gut health, including phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Food and Kindred Products
• Founded: 1996
• Employees: 162
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KI9A

Financial Performance

In 2025, Anpario's revenue was 47.18 million, an increase of 23.51% compared to the previous year's 38.20 million. Earnings were 6.75 million, an increase of 64.20%.

Financial numbers in GBP